Suppr超能文献

肝脏疾病中的微小RNA特征

MicroRNA signatures in liver diseases.

作者信息

Chen Xian-Ming

出版信息

World J Gastroenterol. 2009 Apr 14;15(14):1665-72. doi: 10.3748/wjg.15.1665.

Abstract

MicroRNAs (miRNAs) are an emerging class of highly conserved non-coding small RNAs that regulate gene expression at the post-transcriptional level. It is now clear that miRNAs can potentially regulate every aspect of cellular activity, including differentiation and development, metabolism, proliferation, apoptotic cell death, viral infection and tumorigenesis. Recent studies provide clear evidence that miRNAs are abundant in the liver and modulate a diverse spectrum of liver functions. Deregulation of miRNA expression may be a key pathogenetic factor in many liver diseases including viral hepatitis, hepatocellular cancer and polycystic liver diseases. A clearer understanding of the mechanisms involved in miRNA deregulation will offer new diagnostic and therapeutic strategies to treat liver diseases. Moreover, better understanding of miRNA regulation and identification of tissue-specific miRNA targets employing transgenic/knockout models and/or modulating oligonucleotides will improve our knowledge of liver physiology and diseases.

摘要

微小RNA(miRNA)是一类新出现的高度保守的非编码小RNA,它们在转录后水平调节基因表达。现在已经清楚,miRNA可能潜在地调节细胞活动的各个方面,包括分化与发育、代谢、增殖、凋亡性细胞死亡、病毒感染和肿瘤发生。最近的研究提供了明确的证据,表明miRNA在肝脏中丰富,并调节多种肝脏功能。miRNA表达失调可能是包括病毒性肝炎、肝细胞癌和多囊肝疾病在内的许多肝脏疾病的关键致病因素。更清楚地了解miRNA失调所涉及的机制将为治疗肝脏疾病提供新的诊断和治疗策略。此外,利用转基因/基因敲除模型和/或调节性寡核苷酸更好地了解miRNA调节并鉴定组织特异性miRNA靶标,将增进我们对肝脏生理学和疾病的认识。

相似文献

1
MicroRNA signatures in liver diseases.
World J Gastroenterol. 2009 Apr 14;15(14):1665-72. doi: 10.3748/wjg.15.1665.
2
The role of microRNAs in the management of liver cancer.
Methods Mol Biol. 2012;863:241-51. doi: 10.1007/978-1-61779-612-8_14.
3
The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity.
Int J Mol Sci. 2018 Jan 16;19(1):261. doi: 10.3390/ijms19010261.
4
Regulation of microRNAs and their role in liver development, regeneration and disease.
Int J Biochem Cell Biol. 2014 Sep;54:288-303. doi: 10.1016/j.biocel.2014.04.002. Epub 2014 Apr 13.
5
Biological functions of microRNAs.
Bioorg Khim. 2010 Nov-Dec;36(6):747-52. doi: 10.1134/s1068162010060026.
6
MiR-122 in hepatic function and liver diseases.
Protein Cell. 2012 May;3(5):364-71. doi: 10.1007/s13238-012-2036-3. Epub 2012 May 18.
7
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases.
Gut. 2021 Apr;70(4):784-795. doi: 10.1136/gutjnl-2020-322526. Epub 2020 Oct 30.
8
MicroRNAs and liver disease.
J Hum Genet. 2017 Jan;62(1):75-80. doi: 10.1038/jhg.2016.53. Epub 2016 May 26.
9
MicroRNAs in liver disease.
Gastroenterology. 2012 Jun;142(7):1431-43. doi: 10.1053/j.gastro.2012.04.007. Epub 2012 Apr 11.
10
Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
Pharmacol Res. 2013 Sep;75:48-59. doi: 10.1016/j.phrs.2013.03.004. Epub 2013 Mar 27.

引用本文的文献

1
Hepato-Renal Crosstalk in Acute and Chronic Disease: From Shared Pathways to Therapeutic Targets.
Biomedicines. 2025 Jul 1;13(7):1618. doi: 10.3390/biomedicines13071618.
4
Plasma Extracellular Vesicle-derived MicroRNA Associated with Human Alpha-1 Antitrypsin Deficiency-mediated Liver Disease.
J Clin Transl Hepatol. 2025 Feb 28;13(2):118-129. doi: 10.14218/JCTH.2024.00253. Epub 2024 Nov 19.
5
Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids.
JHEP Rep. 2024 Jun 4;6(9):101126. doi: 10.1016/j.jhepr.2024.101126. eCollection 2024 Sep.
7
Micro RNAs-The Small Big Players in Hepatitis E Virus Infection: A Comprehensive Review.
Biomolecules. 2022 Oct 22;12(11):1543. doi: 10.3390/biom12111543.
8
A Combinational Approach for More Efficient miRNA Biosensing.
Curr Genomics. 2022 Apr 7;23(1):5-25. doi: 10.2174/1389202923666220204160912.
9
Alterations in MicroRNA gene expression profile in liver transplant patients with hepatocellular carcinoma.
BMC Gastroenterol. 2021 Jun 12;21(1):262. doi: 10.1186/s12876-020-01596-2.
10
MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma.
J Hepatocell Carcinoma. 2021 May 12;8:369-385. doi: 10.2147/JHC.S268292. eCollection 2021.

本文引用的文献

1
Biogenesis of small RNAs in animals.
Nat Rev Mol Cell Biol. 2009 Feb;10(2):126-39. doi: 10.1038/nrm2632.
3
Cellular versus viral microRNAs in host-virus interaction.
Nucleic Acids Res. 2009 Mar;37(4):1035-48. doi: 10.1093/nar/gkn1004. Epub 2008 Dec 18.
4
MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc.
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19678-83. doi: 10.1073/pnas.0811166106. Epub 2008 Dec 9.
5
A role for microRNA in cystic liver and kidney diseases.
J Clin Invest. 2008 Nov;118(11):3585-7. doi: 10.1172/JCI36870. Epub 2008 Oct 23.
7
Small RNAs and cancerogenesis.
Biochemistry (Mosc). 2008 May;73(5):514-27. doi: 10.1134/s0006297908050040.
8
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
Gastroenterology. 2008 Jul;135(1):257-69. doi: 10.1053/j.gastro.2008.04.003. Epub 2008 Apr 11.
9
MicroRNAs: novel regulators in cardiac development and disease.
Cardiovasc Res. 2008 Sep 1;79(4):562-70. doi: 10.1093/cvr/cvn137. Epub 2008 May 29.
10
Individual mRNA expression profiles reveal the effects of specific microRNAs.
Genome Biol. 2008;9(5):R82. doi: 10.1186/gb-2008-9-5-r82. Epub 2008 May 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验